Assessing Quality of Life with the Novel QLQ-CAX24 Questionnaire and Body Composition Parameters in Rectal Cancer Patients: A Single-Center Prospective Study
Authors:
- Marco CintoniMarco Cintoni
- Marta PalombaroMPMarta Palombaro
- Pauline RaoulPRPauline Raoul
- Giuditta ChiloiroGCGiuditta Chiloiro
- Angela RomanoARAngela Romano
- Elisa MeldolesiEMElisa Meldolesi
- Flavia De GiacomoFGFlavia De Giacomo
- Elena LeonardiELElena Leonardi
- Gabriele EgidiGEGabriele Egidi
- Futura GrassiFGFutura Grassi
- Gabriele PulciniGPGabriele Pulcini
- Emanuele RinninellaEmanuele Rinninella
Open Access
- 11 December 2024
- Vol. 16 (24) , 4277
Abstract
Background: Patients with rectal cancer (RC) are at risk of developing cancer-related cachexia, a complex metabolic syndrome that can negatively impact quality of life (QoL), treatment tolerance, and clinical response. Objectives: The aim of the study was to explore the possible associations of the novel European Organization for Research and Treatment of Cancer QoL Questionnaire—Cancer Cachexia (EORTC QLQ-CAX24) scores with body composition parameters and physical performance in patients with locally advanced RC (LARC). Methods: This prospective observational study involved RC patients evaluated at the dedicated outpatient clinic of Clinical Nutrition at the Fondazione Policlinico Agostino Gemelli IRCCS. Patients with a confirmed diagnosis of LARC were enrolled between January and December 2023. The body composition parameters were measured using the preoperative computed tomography scan at the level of the third lumbar vertebra as well as using bioimpedance analysis before and after the radiotherapy treatment. QoL was measured by the EORTC QLQ-C30 and EORTC QLQ-CAX24 questionnaires. Results: A total of 56 RC patients were enrolled. Significant associations (p < 0.05) were found between EORTC QLQ-CAX24 values and the presence of cachexia, body composition, handgrip strength, and malnutrition diagnosis. Muscle mass was significatively also associated with EORTC QLQ-CAX24 results, suggesting a link between subjective perception of QoL and objectively measured body composition. Conclusions: The EORTC CAX24 questionnaire can be an effective tool for monitoring changes in cachexia status during radiotherapy, enabling early detection of cachexia-related complications and timely intervention.Keywords
This publication has 36 references indexed in Scilit:
- Multi-Disciplinary Management in Rectal Cancer Survivorship: A Clinical Practice ReviewJournal of Gastrointestinal Cancer, 2023
- Development and validation of questionnaires for eating‐related distress among advanced cancer patients and familiesJournal of Cachexia, Sarcopenia and Muscle, 2022
- ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in EuropeAnnals of Oncology, 2022
- Clinical spectrum of rectal cancer identifies hallmarks of early‐onset patients and next‐generation treatment strategiesCancer Medicine, 2022
- ESPEN practical guideline: Clinical Nutrition in cancerClinical Nutrition, 2021
- Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysisClinical Nutrition, 2020
- GLIM criteria for the diagnosis of malnutrition – A consensus report from the global clinical nutrition communityClinical Nutrition, 2019
- ESPEN expert group recommendations for action against cancer-related malnutritionClinical Nutrition, 2017
- Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trialSupportive Care in Cancer, 2016
- Cancer Cachexia: Mediators, Signaling, and Metabolic PathwaysCell Metabolism, 2012